Engineered to deliver rapid, sustained acid suppression and enhanced gastrointestinal motility, our GI portfolio treats gastroesophageal reflux disease (GERD), erosive esophagitis, and non-ulcer dyspepsia.
Each uncoated tablet contains Diphenoxylate Hydrochloride IP 2.5mg + Atropine Sulphate IP 0.025mg
Each capsule contains Rebeprazole Sodium (as enteric coated pellets) Domperidone IP 30mg as sustained release pellets
Each Enteric coated tablet contains Reaperazole Sodium IP 20mg
Each hard gelatin capsule contains : Rabeprazole Sodium IP 20mg (As enteric coated pellets) + Levosulpiride 75mg (as sustained release)
Each 5 ml contains Sucralfate IP 1gm & Oxetacaine BP 10mg.
Each 5 ml contains Oxethaxaine 10mg BP+Aluminium Hydroxide paste equivalent to Dried aluminium Hydroxide Gel IP 300mg Magnesium Hydroxide equivalent to Magnesium Hydroxide Paste IP150mg +Simethicone IP 125 mg
Each 5 ml contains Aluminimum Hydroxide IP - 125mg eqv to Aluminium Hydroxide IP --- 125mg ; Magnesium Hydroxide paste eqv to Magnesium Hydroxide IP -- 250mg; Simethicone IP - 50mg Sodium Alginate IP --- 100mg
Each uncoated tablet contains: Dried Aluminium Hydroxide IP 300 mg Magnesium Hydroxide IP 150 mg Simethicone IP 40 mg Excipients q's
